Clinical Inquiries

What medical therapies work for gastroparesis?

Author and Disclosure Information

 

References

Metoclopramide improves the sense of fullness for up to 3 weeks, may improve nausea, and doesn’t affect vomiting or anorexia.

Levosulpiride. One crossover study compared 25 mg levosulpiride with 10 mg cisapride (both given orally 3 times a day) on gastroparesis symptoms and gastric emptying. Each medication was given for one month (washout duration not given). The study found similar efficacy between levosulpiride and cisapride in terms of improvement in gastric emptying rates and total symptom scores.7 No studies compare levosulpiride to placebo.

Nortriptyline. A multicenter, parallel-group, double-blind RCT comparing 75 mg/d nortriptyline for 15 weeks with placebo in adult patients with moderate to severe symptoms of idiopathic gastroparesis for at least 6 months found that nortriptyline didn’t improve symptoms.8

Botulinum toxin A. An RCT comparing a single injection of 200 units intrapyloric botulinum toxin A with placebo in adult patients with severe gastroparesis symptoms found that botulinum toxin A didn’t result in symptomatic improvement.9 A crossover trial comparing 100 units monthly intrapyloric botulinum toxin A for 3 months with placebo in patients with gastroparesis found that neither symptoms nor rate of gastric emptying changed with the toxin.10

RECOMMENDATIONS

The 2013 guidelines from the American College of Gastroenterology list metoclopramide as the first-line agent for gastroparesis requiring medical therapy, followed by domperidone and then erythromycin (all based on “moderate quality evidence”). Antiemetic agents are also recommended for symptom control.11

Pages

Evidence-based answers from the Family Physicians Inquiries Network

Recommended Reading

H. pylori antibiotic resistance reaches ‘alarming levels’
MDedge Family Medicine
Increased incidence of GI, colorectal cancers seen in young, obese patients
MDedge Family Medicine
Obesity, weight gain linked to colorectal cancer risk in younger women
MDedge Family Medicine
Blood test outreach, navigation could close colorectal cancer screening gap
MDedge Family Medicine
Aspirin cuts risk of ovarian and liver cancer
MDedge Family Medicine
Novel score predicts esophageal varices in patients with cirrhosis prior to EGD
MDedge Family Medicine
Endocuff decreases withdrawal time but not detection rate during colonoscopy
MDedge Family Medicine
Primary care holds key to curbing early-onset colorectal cancer
MDedge Family Medicine
Constipation because of deportation-related trauma
MDedge Family Medicine
FDA approves adalimumab biosimilar Hyrimoz
MDedge Family Medicine